Yaping Qin
100 Kexue Avenue
Zhengzhou, 450001, China
Zhengzhou, 450001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C de novo mutation: A case report.
Journal: Frontiers in pharmacology
Published: October 03, 2022
Case Report: A Case Report of a Histological Transformation of ALK-Rearranged Adenocarcinoma With High Expression of PD-L1 to Squamous Cell Carcinoma After Treatment With Alectinib.
Journal: Pathology oncology research : POR
Published: December 04, 2020
Missense Variant of Endoplasmic Reticulum Region of WFS1 Gene Causes Autosomal Dominant Hearing Loss without Syndromic Phenotype.
Journal: BioMed research international
Published: November 24, 2020
Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans.
Journal: Scientific reports
Published: July 01, 2020
Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy.
Journal: ACS applied bio materials
Published: March 18, 2019
The design of high affinity human PD-1 mutants by using molecular dynamics simulations (MD).
Journal: Cell communication and signaling : CCS
Published: February 28, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026